Insider Transactions in Q1 2025 at Armata Pharmaceuticals, Inc. (ARMP)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Mar 14 2025	Pierre Kyme Chief Business Officer	SELL Payment of exercise price or tax liability	Direct	1,027 -8.92%	$1,027 $1.95 P/Share
Mar 14 2025	Deborah Birx Chief Executive Officer	SELL Payment of exercise price or tax liability	Direct	6,061 -2.56%	$6,061 $1.95 P/Share

Receive a notification when an Institution or Guru buys or sells ARMP shares.

Notify only if

Value

Get notified when an Armata Pharmaceuticals, Inc. insider buys or sells ARMP shares.

Notify only if

Operation

Value

Type

Receive news related to Armata Pharmaceuticals, Inc.